clinical trial · NCT05954910
A Study to Evaluate the Effectiveness and Safety of Polatuzumab in Real World Clinical Practice Among Adult Chinese Participants With Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell LymphomaPolatuzumab Vedotin
brief summary
The purpose of this study is to assess the progression free survival (PFS) in the real-world settings of polatuzumab among Chinese diffuse large B cell lymphoma (DLBCL) participants.
started
Aug 25, 2023
primary completion
May 31, 2027
completion
May 31, 2027
last updated
Jul 1, 2026
official title
The Effectiveness and Safety of Polatuzumab in Real-World Clinical Practice Among Chinese Adult Patients With Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter, Registry Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol